購(gòu)物車(chē)
幫助
021-54845833/15800441009
中文名稱(chēng)： 兔抗UBA2多克隆抗體
技術(shù)規(guī)格
|
Background: |
Posttranslational modification of proteins by the addition of the small protein SUMO (see SUMO1; MIM 601912), or sumoylation, regulates protein structure and intracellular localization. SAE1 (MIM 613294) and UBA2 form a heterodimer that functions as a SUMO-activating enzyme for the sumoylation of proteins (Okuma et al., 1999 [PubMed 9920803]). |
|
Applications: |
WB, IHC |
|
Name of antibody: |
UBA2 |
|
Immunogen: |
Synthesized peptide derived from C-terminal of human Uba2. |
|
Full name: |
ubiquitin-like modifier activating enzyme 2 |
|
Synonyms： |
ARX; SAE2; HRIHFB2115 |
|
SwissProt: |
Q9UBT2 |
|
IHC positive control: |
Human lung carcinoma tissue |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
71 kDa |
|
WB Positive control: |
293 cells lysates treated with UV (5mins) |
|
WB Recommended dilution: |
500-3000 |
